|
|
P J French, J H van Doorninck, R H Peters, E Verbeek, N A Ameen, C R Marino, H R de Jonge, J Bijman, B J Scholte
J Clin Invest. 1996;
98(6):1304
doi:10.1172/JCI118917
Abstract |
Full text
| PDF

T
he most prevalent mutation (delta F508) in cystic fibrosis patients inhibits maturation and transfer to the plasma membrane of the mutant cystic fibrosis transmembrane conductance regulator (CFTR). We have analyzed the properties of a delta F508 CFTR mouse model, which we described recently. We show that the mRNA levels of mutant CFTR are normal in all tissues examined. Therefore the reduced mRNA levels reported in two similar models may be related to their intronic transcription units. Maturation of mutant CFTR was greatly reduced in freshly excised oviduct, compared with normal. Accumulation of mutant CFTR antigen in the apical region of jejunum crypt enterocytes was not observed, in contrast to normal mice. In cultured gallbladder epithelial cells from delta F508 mice, CFTR chloride channel activity could be detected at only two percent of the normal frequency. However, in mutant cells that were grown at reduced temperature the channel frequency increased to over sixteen percent of the normal level at that temperature. The biophysical characteristics of the mutant channel were not significantly different from normal. In homozygous delta F508 mice we did not observe a significant effect of genetic background on the level of residual chloride channel activity, as determined by the size of the forskolin response in Ussing chamber experiments. Our data show that like its human homologue, mouse delta F508-CFTR is a temperature sensitive processing mutant. The delta F508 mouse is therefore a valid in vivo model of human delta F508-CFTR. It may help us to elucidate the processing pathways of complex membrane proteins. Moreover, it may facilitate the discovery of new approaches towards therapy of cystic fibrosis.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(26)
| Title and authors |
Publication |
Year |
Mouse models of cystic fibrosis: Phenotypic analysis and research applications
Martina Wilke, Ruvalic M. Buijs-Offerman, Jamil Aarbiou, William H. Colledge, David N. Sheppard, Lhousseine Touqui, Alice Bot, Huub Jorna, Hugo R. De Jonge, Bob J. Scholte
|
Journal of Cystic Fibrosis
|
2011 |
Identification of a NBD1-Binding Pharmacological Chaperone that Corrects the Trafficking Defect of F508del-CFTR
Heidi M. Sampson, Renaud Robert, Jie Liao, Elizabeth Matthes, Graeme W. Carlile, John W. Hanrahan, David Y. Thomas
|
Chemistry & Biology
|
2011 |
Targeting F508del-CFTR to develop rational new therapies for cystic fibrosis
Zhi-wei Cai, Jia Liu, Hong-yu Li, David N Sheppard
|
Acta Pharmacol Sin
|
2011 |
The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cells
Antonius Bronckers, Lida Kalogeraki, Huub J.N. Jorna, Martina Wilke, Theodore J. Bervoets, Donacian M. Lyaruu, Behrouz Zandieh-Doulabi, Pamela DenBesten, Hugo de Jonge
|
Bone
|
2010 |
Osteopenia in Cftr-deltaF508 mice
Josée Paradis, Martina Wilke, Christina K. Haston
|
Journal of Cystic Fibrosis
|
2010 |
CFTR-deficiency renders mice highly susceptible to cutaneous symptoms during mite infestation
Yasuaki Hashimoto, Tsuyoshi Shuto, Shota Mizunoe, Azusa Tomita, Tomoaki Koga, Takashi Sato, Motohiro Takeya, Mary Ann Suico, Akiko Niibori, Takuya Sugahara, Shogo Shimasaki, Takashi Sugiyama, Bob Scholte, Hirofumi Kai
|
Lab Invest
|
2010 |
Expression of Intestinal and Lung Alkaline Sphingomyelinase and Neutral Ceramidase in Cystic Fibrosis F508del Transgenic Mice
Lena Ohlsson, Lena Hjelte, Michael Hühn, Bob J Scholte, Martina Wilke, Malin Flodström-Tullberg, Åke Nilsson
|
Journal of Pediatric Gastroenterology and Nutrition
|
2008 |
CFTR and defective endocytosis: new insights in the renal phenotype of cystic fibrosis
François Jouret, Olivier Devuyst
|
Pflugers Arch - Eur J Physiol
|
2008 |
Functional expression of cystic fibrosis transmembrane conductance regulator in rat oviduct epithelium
Minhui Chen, Jianyang Du, Weijian Jiang, Wulin Zuo, Fang Wang, Manhui Li, Zhongluan Wu, Hsiaochang Chan, Wenliang Zhou
|
Acta Biochimica et Biophysica Sinica
|
2008 |
Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice
L E Ostrowski, W Yin, P S Diggs, T D Rogers, W K O'Neal, B R Grubb
|
Gene Ther
|
2007 |
|